Placental regulation of maternal-fetal interactions and brain development

Developmental Neurobiology

Volumn 72, Issue 10, 2012, Pages 1317-1326

  Hsiao, Elaine Y ^a   Patterson, Paul H ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Autism; Cerebral palsy; Intrauterine; Schizophrenia; Trophoblast

Indexed keywords

ANTIBODY;

ARTICLE; AUTISM; AUTOIMMUNITY; BRAIN DEVELOPMENT; CELL HYPOXIA; CELL INVASION; CEREBRAL PALSY; EMBRYO DEATH; ENDOCRINE FUNCTION; FETUS DISEASE; HUMAN; IMMUNOLOGICAL TOLERANCE; INTRAUTERINE GROWTH RETARDATION; MOTHER FETUS RELATIONSHIP; NEUROLOGIC DISEASE; NONHUMAN; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PLACENTA FUNCTION; PRIORITY JOURNAL; SCHIZOPHRENIA; TROPHOBLAST;

ANIMALS; BRAIN; FEMALE; FETAL DEVELOPMENT; FETUS; HUMANS; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY;

EID: 84865836058     PISSN: 19328451     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.22045     Document Type: Article

References (75)

1. Abrahams VM, Visintin I, Aldo PB, Guller S, Romero R, Mor G. 2005. A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol 175: 8096-8104.
2. Aluvihare VR, Kallikourdis M, Betz AG. 2004. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5: 266-271.
3. Alvir JM, Woerner MG, Gunduz H, Degreef G, Lieberman JA. 1999. Obstetric complications predict treatment response in first-episode schizophrenia. Psychological Med 29: 621-627.
4. Anderson GM, Jacobs-Stannard A, Chawarska K, Volkmar FR, Kliman HJ. 2007. Placental trophoblast inclusions in autism spectrum disorder. Biol Psychiatry 61: 487-491.
5. Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M, Parner ET. 2010. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40: 1423-1430.
6. Bale TL, Baram TZ, Brown AS, Goldstein JM, Insel TR, McCarthy MM, Nemeroff CB, etal. 2010. Early life programming and neurodevelopmental disorders. Biol Psychiatry 68: 314-319.
7. Barker DJ, Bull AR, Osmond C, Simmonds SJ. 1990. Fetal and placental size and risk of hypertension in adult life. BMJ 301: 259-262.
8. Bassan H, Kidron D, Bassan M, Rotstein M, Kariv N, Giladi E, Davidson A, et al. 2010. The effects of vascular intrauterine growth retardation on cortical astrocytes. J Maternal-Fetal Neonatal Med 23: 595-600.
9. Bonnin A, Goeden N, Chen K, Wilson ML, King J, Shih JC, Blakely RD, et al. 2011. A transient placental source of serotonin for the fetal forebrain. Nature 472: 347-350.
10. Braunschweig D, Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Croen LA, Pessah IN, et al. 2008. Autism: Maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 29: 226-231.
11. Brown AS, Patterson PH. 2011. Maternal infection and schizophrenia: Implications for prevention. Schizophrenia Bull 37: 284-290.
12. Brown AS, Susser ES. 2008. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophrenia Bull 34: 1054-1063.
13. Bulmer JN, Williams PJ, Lash GE. 2010. Immune cells in the placental bed. Int J Dev Biol 54: 281-294.
14. Carpentier PA, Dingman AL, Palmer TD. 2011. Placental TNF-alpha signaling in illness-induced complications of pregnancy. Am J Pathol 178: 2802-2810.
15. Cartwright JE, Fraser R, Leslie K, Wallace AE, James JL. 2010. Remodelling at the maternal-fetal interface: Relevance to human pregnancy disorders. Reproduction 140: 803-813.
16. Cartwright JE, Keogh RJ, Tissot van Patot MC. 2007. Hypoxia and placental remodelling. Adv Exp Med Biol 618: 113-126.
17. Clarke MC, Tanskanen A, Huttunen M, Leon DA, Murray RM, Jones PB, Cannon M. 2011. Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: Evidence from a population-based longitudinal study. Am J Psychiatry 168: 1295-1302.
18. Coe CL, Lubach GR. 2000. Prenatal influences on neuroimmune set points in infancy. Ann NY Acad Sci 917: 468-477.
19. Collins KL, Baltimore D. 1999. HIV's evasion of the cellular immune response. Immunological Rev 168: 65-74.
20. Cudihy D, Lee RV. 2009. The pathophysiology of pre-eclampsia: Current clinical concepts. J Obstetrics Gynaecol 29: 576-582.
21. Dahlgren J, Samuelsson AM, Jansson T, Holmang A. 2006. Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation. Pediatric Res 60: 147-151.
22. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. 2008. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 9: 46-56.
23. Dedovic K, Duchesne A, Andrews J, Engert V, Pruessner JC. 2009. The brain and the stress axis: The neural correlates of cortisol regulation in response to stress. NeuroImage 47: 864-871.
24. Dowling O, Chatterjee PK, Gupta M, Tam Tam HB, Xue X, Lewis D, Rochelson B, et al. 2012. Magnesium sulfate reduces bacterial LPS-induced inflammation at the maternal-fetal interface. Placenta 33: 392-398.
25. Doyle LW. 2012. Antenatal magnesium sulfate and neuroprotection. Current Opin Pediatrics 24: 154-159.
26. Fatemi SH, Folsom TD, Rooney RJ, Mori S, Kornfield TE, Reutiman TJ, Kneeland RE, et al. 2011. The viral theory of schizophrenia revisited: Abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring. Neuropharmacology 62: 1290-1298.
27. Fernandez-Twinn DS, Ozanne SE. 2010. Early life nutrition and metabolic programming. Ann NY Acad Sci 1212: 78-96.
28. Fowden AL, Forhead AJ, Coan PM, Burton GJ. 2008. The placenta and intrauterine programming. J Neuroendocrinol 20: 439-450.
29. Fruh K, Gruhler A, Krishna RM, Schoenhals GJ. 1999. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway. Immunological Rev 168: 157-166.
30. Gardener H, Spiegelman D, Buka SL. 2009. Prenatal risk factors for autism: Comprehensive meta-analysis. Br J Psychiatry 195: 7-14.
31. Gekas C, Dieterlen-Lievre F, Orkin SH, Mikkola HK. 2005. The placenta is a niche for hematopoietic stem cells. Dev Cell 8: 365-375.
32. Girard S, Tremblay L, Lepage M, Sebire G. 2010. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J Immunol 184: 3997-4005.
33. Hazan AD, Smith SD, Jones RL, Whittle W, Lye SJ, Dunk CE. 2010. Vascular-leukocyte interactions: Mechanisms of human decidual spiral artery remodeling in vitro. Am J Pathol 177: 1017-1030.
34. Hirst JJ, Walker DW, Yawno T, Palliser HK. 2009. Stress in pregnancy: A role for neuroactive steroids in protecting the fetal and neonatal brain. Dev Neurosci 31: 363-377.
35. Holcberg G, Sapir O, Hallak M, Alaa A, Shorok HY, David Y, Katz M, et al. 2004. Selective vasodilator effect of magnesium sulfate in human placenta. Am J Reproductive Immunol 51: 192-197.
36. Hsiao EY, McBride S, Chow J, Mazmanian SK, Patterson PH. 2011. Modeling an autism risk factor in mice leads to permanent changes in the immune system. Cell Symposium, Autism Spectrum Disorders: From Mechanisms to Therapies, Arlington, VA.
37. Hsiao EY, Patterson PH. 2011. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immunity 25: 604-615.
38. Hutton LC, Castillo-Melendez M, Smythe GA, Walker DW. 2008. Microglial activation, macrophage infiltration, and evidence of cell death in the fetal brain after uteroplacental administration of lipopolysaccharide in sheep in late gestation. Am J Obstetrics Gynecol 198: 117 e111-111.
39. Hutton LC, Castillo-Melendez M, Walker DW. 2007. Uteroplacental inflammation results in blood brain barrier breakdown, increased activated caspase 3 and lipid peroxidation in the late gestation ovine fetal cerebellum. Dev Neurosci 29: 341-354.
40. Ilievski V, Lu SJ, Hirsch E. 2007. Activation of toll-like receptors 2 or 3 and preterm delivery in the mouse. Reproductive Sci 14: 315-320.
41. Jansson T, Powell TL. 2007. Role of the placenta in fetal programming: Underlying mechanisms and potential interventional approaches. Clin Sci 113: 1-13.
42. Jarvis S, Glinianaia SV, Blair E. 2006. Cerebral palsy and intrauterine growth. Clin Perinatol 33: 285-300.
43. Kadyrov M, Kosanke G, Kingdom J, Kaufmann P. 1998. Increased fetoplacental angiogenesis during first trimester in anaemic women. Lancet 352: 1747-1749.
44. Koga K, Mor G. 2010. Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reproductive Immunol 63: 587-600.
45. Kovac CM, Howard BC, Pierce BT, Hoeldtke NJ, Calhoun BC, Napolitano PG. 2003. Fetoplacental vascular tone is modified by magnesium sulfate in the preeclamptic ex vivo human placental cotyledon. Am J Obstetrics Gynecol 189: 839-842.
46. Krechowec SO, Vickers M, Gertler A, Breier BH. 2006. Prenatal influences on leptin sensitivity and susceptibility to diet-induced obesity. J Endocrinol 189: 355-363.
47. Limperopoulos C, Bassan H, Sullivan NR, Soul JS, Robertson RLJr, Moore M, Ringer SA, et al. 2008. Positive screening for autism in ex-preterm infants: prevalence and risk factors. Pediatrics 121: 758-765.
48. Malkova NV, Yu CZ, Hsiao EY, Moore MJ, Patterson PH. 2012. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 26: 607-616.
49. Medawar PB. 1953. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol. 7: 320-388.
50. Moffett A, Loke C. 2006. Immunology of placentation in eutherian mammals. Nat Rev Immunol 6: 584-594.
51. O'Callaghan ME, MacLennan AH, Gibson CS, McMichael GL, Haan EA, Broadbent JL, Goldwater PN, etal. 2011. Epidemiologic associations with cerebral palsy. Obstetrics and gynecology 118: 576-582.
52. Okada Y, Ueshin Y, Isotani A, Saito-Fujita T, Nakashima H, Kimura K, Mizoguchi A, et al. 2007. Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer. Nat Biotechnol 25: 233-237.
53. Onore C, Careaga M, Ashwood P. 2011. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immunity 26: 383-392.
54. Patterson PH. 2007. Neuroscience. Maternal effects on schizophrenia risk. Science 318: 576-577.
55. Patterson PH. 2009. Immune involvement in schizophrenia and autism: Etiology, pathology and animal models. Behav Brain Res 204: 313-321.
56. Patterson PH. 2011. Maternal infection and immune involvement in autism. Trends Mol Med 17: 389-394.
57. Petraglia F, Imperatore A, Challis JR. 2010. Neuroendocrine mechanisms in pregnancy and parturition. Endocrine Rev 31: 783-816.
58. Preti A, Cardascia L, Zen T, Marchetti M, Favaretto G, Miotto P. 2000. Risk for obstetric complications and schizophrenia. Psychiatry Res 96: 127-139.
59. Redline RW. 2006. Placental pathology and cerebral palsy. Clin Perinatol 33: 503-516.
60. Redmer DA, Wallace JM, Reynolds LP. 2004. Effect of nutrient intake during pregnancy on fetal and placental growth and vascular development. Domestic Animal Endocrinol 27: 199-217.
61. Renaud SJ, Graham CH. 2008. The role of macrophages in utero-placental interactions during normal and pathological pregnancy. Immunological Invest 37: 535-564.
62. Rhodes KE, Gekas C, Wang Y, Lux CT, Francis CS, Chan DN, Conway S, et al. 2008. The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell 2: 252-263.
63. Roberts CT, Sohlstrom A, Kind KL, Earl RA, Khong TY, Robinson JS, Owens PC, et al. 2001. Maternal food restriction reduces the exchange surface area and increases the barrier thickness of the placenta in the guinea-pig. Placenta 22: 177-185.
64. Sacco R, Curatolo P, Manzi B, Militerni R, Bravaccio C, Frolli A, Lenti C, et al. 2010. Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. Autism Res: Official J Int Soc Autism Res 3: 237-252.
65. Scaife PJ, Searle RF, Robson SC, Innes BA, Bulmer JN. 2003. A comparison of cytotoxic decidual leukocyte populations in early and late pregnancy. J Soc Gynecol Investig 10: 360A.
66. Segerstrom SC, Miller GE. 2004. Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychological Bull 130: 601-630.
67. Sibley CP, Turner MA, Cetin I, Ayuk P, Boyd CA, D'Souza SW, Glazier JD, et al. 2005. Placental phenotypes of intrauterine growth. Pediatric Res 58: 827-832.
68. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. 2007. Maternal immune activation alters fetal brain development through interleukin-6. The J Neurosci : Official J Soc Neurosci 27: 10695-10702.
69. Sobrian SK, Vaughn VT, Ashe WK, Markovic B, Djuric V, Jankovic BD. 1997. Gestational exposure to loud noise alters the development and postnatal responsiveness of humoral and cellular components of the immune system in offspring. Environ Res 73: 227-241.
70. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. 1995. T cell awareness of paternal alloantigens during pregnancy. Science 270: 630-633.
71. Tincani A, Bazzani C, Zingarelli S, Lojacono A. 2008. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: Clinical characteristics, diagnosis, pathogenesis, and treatment. Seminars Thrombosis Hemostasis 34: 267-273.
72. Trowsdale J, Betz AG. 2006. Mother's little helpers: Mechanisms of maternal-fetal tolerance. Nat Immunol 7: 241-246.
73. Warning JC, McCracken SA, Morris JM. 2011. A balancing act: Mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction 141: 715-724.
74. Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. 2004. Association of rheumatologic disease with preeclampsia. Obstetrics Gynecol 103: 1190-1193.
75. Zhang J, Sun R, Wei H, Wu D, Tian Z. 2007. Toll-like receptor 3 agonist enhances IFN-gamma and TNF-alpha production by murine uterine NK cells. Int Immunopharmacol 7: 588-596.